Henry Schein, Inc. (0L3C.L)
USD 65.74
(2.83%)
USD 65.74
(2.83%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 12.33 Billion USD | -2.44% |
| 2022 | 12.64 Billion USD | 1.98% |
| 2021 | 12.4 Billion USD | 22.55% |
| 2020 | 10.11 Billion USD | 1.34% |
| 2019 | 9.98 Billion USD | -24.36% |
| 2018 | 13.2 Billion USD | 5.94% |
| 2017 | 12.46 Billion USD | 7.69% |
| 2016 | 11.57 Billion USD | 8.86% |
| 2015 | 10.62 Billion USD | 2.49% |
| 2014 | 10.37 Billion USD | 8.48% |
| 2013 | 9.56 Billion USD | 6.94% |
| 2012 | 8.93 Billion USD | 4.8% |
| 2011 | 8.53 Billion USD | 13.33% |
| 2010 | 7.52 Billion USD | 15.12% |
| 2009 | 6.53 Billion USD | 2.24% |
| 2008 | 6.39 Billion USD | 8.02% |
| 2007 | 5.92 Billion USD | 14.89% |
| 2006 | 5.15 Billion USD | 11.16% |
| 2005 | 4.63 Billion USD | 14.18% |
| 2004 | 4.06 Billion USD | 21.06% |
| 2003 | 3.35 Billion USD | 18.72% |
| 2002 | 2.82 Billion USD | 10.43% |
| 2001 | 2.55 Billion USD | 7.41% |
| 2000 | 2.38 Billion USD | 4.2% |
| 1999 | 2.28 Billion USD | 18.94% |
| 1998 | 1.92 Billion USD | 26.59% |
| 1997 | 1.51 Billion USD | 82.9% |
| 1996 | 830 Million USD | 34.7% |
| 1995 | 616.2 Million USD | 26.63% |
| 1994 | 486.6 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 3.13 Billion USD | -1.13% |
| 2024 Q1 | 3.17 Billion USD | 5.14% |
| 2023 Q1 | 3.06 Billion USD | -9.23% |
| 2023 Q3 | 3.16 Billion USD | 2.0% |
| 2023 Q4 | 3.01 Billion USD | -4.59% |
| 2023 FY | 12.33 Billion USD | -2.44% |
| 2023 Q2 | 3.1 Billion USD | 1.31% |
| 2022 Q1 | 3.17 Billion USD | -4.55% |
| 2022 FY | 12.64 Billion USD | 1.98% |
| 2022 Q4 | 3.37 Billion USD | 9.91% |
| 2022 Q3 | 3.06 Billion USD | 1.22% |
| 2022 Q2 | 3.03 Billion USD | -4.69% |
| 2021 Q4 | 3.33 Billion USD | 4.79% |
| 2021 FY | 12.4 Billion USD | 22.55% |
| 2021 Q1 | 2.92 Billion USD | -7.61% |
| 2021 Q2 | 2.96 Billion USD | 1.44% |
| 2021 Q3 | 3.17 Billion USD | 7.11% |
| 2020 Q2 | 1.68 Billion USD | -30.65% |
| 2020 Q4 | 3.16 Billion USD | 11.46% |
| 2020 Q3 | 2.84 Billion USD | 68.61% |
| 2020 FY | 10.11 Billion USD | 1.34% |
| 2020 Q1 | 2.42 Billion USD | -8.99% |
| 2019 Q4 | 2.66 Billion USD | 6.38% |
| 2019 FY | 9.98 Billion USD | -24.36% |
| 2019 Q1 | 2.36 Billion USD | -30.07% |
| 2019 Q2 | 2.44 Billion USD | 3.71% |
| 2019 Q3 | 2.5 Billion USD | 2.49% |
| 2018 Q4 | 3.37 Billion USD | 2.91% |
| 2018 Q2 | 3.32 Billion USD | 3.3% |
| 2018 Q1 | 3.22 Billion USD | -2.94% |
| 2018 Q3 | 3.27 Billion USD | -1.41% |
| 2018 FY | 13.2 Billion USD | 5.94% |
| 2017 FY | 12.46 Billion USD | 7.69% |
| 2017 Q4 | 3.31 Billion USD | 4.97% |
| 2017 Q2 | 3.05 Billion USD | 4.67% |
| 2017 Q3 | 3.16 Billion USD | 3.32% |
| 2017 Q1 | 2.92 Billion USD | -6.34% |
| 2016 Q3 | 2.86 Billion USD | -0.26% |
| 2016 Q1 | 2.71 Billion USD | -4.84% |
| 2016 Q2 | 2.87 Billion USD | 5.89% |
| 2016 Q4 | 3.12 Billion USD | 8.93% |
| 2016 FY | 11.57 Billion USD | 8.86% |
| 2015 Q3 | 2.68 Billion USD | 2.15% |
| 2015 Q1 | 2.46 Billion USD | -8.82% |
| 2015 Q2 | 2.62 Billion USD | 6.72% |
| 2015 Q4 | 2.85 Billion USD | 6.15% |
| 2015 FY | 10.62 Billion USD | 2.49% |
| 2014 FY | 10.37 Billion USD | 8.48% |
| 2014 Q1 | 2.43 Billion USD | -3.81% |
| 2014 Q2 | 2.61 Billion USD | 7.62% |
| 2014 Q3 | 2.62 Billion USD | 0.32% |
| 2014 Q4 | 2.7 Billion USD | 2.99% |
| 2013 Q3 | 2.34 Billion USD | -1.79% |
| 2013 Q4 | 2.52 Billion USD | 7.55% |
| 2013 Q2 | 2.39 Billion USD | 4.29% |
| 2013 Q1 | 2.29 Billion USD | -4.77% |
| 2013 FY | 9.56 Billion USD | 6.94% |
| 2012 Q3 | 2.23 Billion USD | 1.34% |
| 2012 Q4 | 2.4 Billion USD | 7.95% |
| 2012 Q1 | 2.09 Billion USD | -10.3% |
| 2012 FY | 8.93 Billion USD | 4.8% |
| 2012 Q2 | 2.2 Billion USD | 4.88% |
| 2011 Q3 | 2.11 Billion USD | -0.89% |
| 2011 Q2 | 2.13 Billion USD | 9.39% |
| 2011 Q4 | 2.34 Billion USD | 10.82% |
| 2011 FY | 8.53 Billion USD | 13.33% |
| 2011 Q1 | 1.94 Billion USD | -3.75% |
| 2010 Q2 | 1.84 Billion USD | 5.06% |
| 2010 FY | 7.52 Billion USD | 15.12% |
| 2010 Q4 | 2.02 Billion USD | 6.87% |
| 2010 Q3 | 1.89 Billion USD | 2.39% |
| 2010 Q1 | 1.76 Billion USD | -1.44% |
| 2009 FY | 6.53 Billion USD | 2.24% |
| 2009 Q1 | 1.48 Billion USD | -5.4% |
| 2009 Q2 | 1.61 Billion USD | 8.22% |
| 2009 Q3 | 1.65 Billion USD | 3.01% |
| 2009 Q4 | 1.78 Billion USD | 7.63% |
| 2008 Q4 | 1.57 Billion USD | -4.68% |
| 2008 FY | 6.39 Billion USD | 8.02% |
| 2008 Q2 | 1.64 Billion USD | 7.82% |
| 2008 Q1 | 1.52 Billion USD | -11.17% |
| 2008 Q3 | 1.65 Billion USD | 0.35% |
| 2007 Q3 | 1.5 Billion USD | 8.55% |
| 2007 Q1 | 1.33 Billion USD | -10.99% |
| 2007 Q4 | 1.71 Billion USD | 14.07% |
| 2007 FY | 5.92 Billion USD | 14.89% |
| 2007 Q2 | 1.38 Billion USD | 3.96% |
| 2006 Q3 | 1.27 Billion USD | 4.23% |
| 2006 Q4 | 1.49 Billion USD | 17.84% |
| 2006 Q2 | 1.22 Billion USD | 5.04% |
| 2006 Q1 | 1.16 Billion USD | -13.5% |
| 2006 FY | 5.15 Billion USD | 11.16% |
| 2005 Q1 | 1.1 Billion USD | -7.78% |
| 2005 Q2 | 1.14 Billion USD | 3.65% |
| 2005 Q3 | 1.12 Billion USD | -1.42% |
| 2005 Q4 | 1.34 Billion USD | 19.35% |
| 2005 FY | 4.63 Billion USD | 14.18% |
| 2004 Q2 | 945.69 Million USD | 6.66% |
| 2004 Q3 | 1.03 Billion USD | 9.3% |
| 2004 FY | 4.06 Billion USD | 21.06% |
| 2004 Q4 | 1.19 Billion USD | 15.55% |
| 2004 Q1 | 886.63 Million USD | -6.37% |
| 2003 Q2 | 776.16 Million USD | 5.17% |
| 2003 Q1 | 737.99 Million USD | -1.26% |
| 2003 Q3 | 892.71 Million USD | 15.02% |
| 2003 FY | 3.35 Billion USD | 18.72% |
| 2003 Q4 | 946.92 Million USD | 6.07% |
| 2002 Q1 | 647.09 Million USD | -7.33% |
| 2002 FY | 2.82 Billion USD | 10.43% |
| 2002 Q4 | 747.4 Million USD | -1.54% |
| 2002 Q3 | 759.07 Million USD | 13.05% |
| 2002 Q2 | 671.43 Million USD | 3.76% |
| 2001 FY | 2.55 Billion USD | 7.41% |
| 2001 Q1 | 593.89 Million USD | -9.56% |
| 2001 Q2 | 606.28 Million USD | 2.09% |
| 2001 Q3 | 659.77 Million USD | 8.82% |
| 2001 Q4 | 698.28 Million USD | 5.84% |
| 2000 Q2 | 568.17 Million USD | 2.59% |
| 2000 FY | 2.38 Billion USD | 4.2% |
| 2000 Q1 | 553.81 Million USD | -9.4% |
| 2000 Q3 | 603.03 Million USD | 6.14% |
| 2000 Q4 | 656.7 Million USD | 8.9% |
| 1999 Q1 | 536.3 Million USD | 6.68% |
| 1999 Q4 | 611.3 Million USD | 5.62% |
| 1999 Q3 | 578.8 Million USD | 3.49% |
| 1999 Q2 | 559.3 Million USD | 4.29% |
| 1999 FY | 2.28 Billion USD | 18.94% |
| 1998 Q1 | 403 Million USD | -33.54% |
| 1998 Q2 | 427.9 Million USD | 6.18% |
| 1998 Q4 | 502.7 Million USD | 2.05% |
| 1998 Q3 | 492.6 Million USD | 15.12% |
| 1998 FY | 1.92 Billion USD | 26.59% |
| 1997 Q2 | 263.1 Million USD | 9.4% |
| 1997 FY | 1.51 Billion USD | 82.9% |
| 1997 Q1 | 240.5 Million USD | 1.31% |
| 1997 Q4 | 606.4 Million USD | 85.1% |
| 1997 Q3 | 327.6 Million USD | 24.52% |
| 1996 Q4 | 237.4 Million USD | 11.72% |
| 1996 FY | 830 Million USD | 34.7% |
| 1996 Q1 | 185.4 Million USD | 0.93% |
| 1996 Q2 | 194.7 Million USD | 5.02% |
| 1996 Q3 | 212.5 Million USD | 9.14% |
| 1995 Q2 | 139.8 Million USD | 2.79% |
| 1995 Q4 | 183.7 Million USD | 17.23% |
| 1995 FY | 616.2 Million USD | 26.63% |
| 1995 Q1 | 136 Million USD | -2.65% |
| 1995 Q3 | 156.7 Million USD | 12.09% |
| 1994 Q1 | 108.4 Million USD | 0.0% |
| 1994 Q2 | 115.8 Million USD | 6.83% |
| 1994 FY | 486.6 Million USD | 0.0% |
| 1994 Q4 | 139.7 Million USD | 13.85% |
| 1994 Q3 | 122.7 Million USD | 5.96% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Phreesia, Inc. | 356.29 Million USD | -3363.103% |
| Accuray Incorporated | 446.55 Million USD | -2663.178% |
| Align Technology, Inc. | 3.86 Billion USD | -219.476% |
| Elevance Health Inc. | 171.34 Billion USD | 92.799% |
| AxoGen, Inc. | 159.01 Million USD | -7659.792% |
| Boston Scientific Corporation | 14.24 Billion USD | 13.35% |
| CVS Health Corporation | 357.77 Billion USD | 96.551% |
| Cardinal Health, Inc. | 226.82 Billion USD | 94.56% |
| Centene Corporation | 141.26 Billion USD | 91.265% |
| DaVita Inc. | 12.14 Billion USD | -1.638% |
| HCA Healthcare, Inc. | 64.96 Billion USD | 81.008% |
| Hologic, Inc. | 4.03 Billion USD | -206.156% |
| Humana Inc. | 106.37 Billion USD | 88.4% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | -237.043% |
| Laboratory Corporation of America Holdings | 12.16 Billion USD | -1.459% |
| Masimo Corporation | 2.04 Billion USD | -502.461% |
| McKesson Corporation | 308.95 Billion USD | 96.006% |
| Patterson Companies, Inc. | 6.56 Billion USD | -87.858% |
| Quest Diagnostics Incorporated | 9.25 Billion USD | -33.366% |
| ResMed Inc. | 4.68 Billion USD | -163.356% |
| Teladoc Health, Inc. | 2.6 Billion USD | -374.137% |
| Universal Health Services, Inc. | 14.28 Billion USD | 13.604% |
| Veeva Systems Inc. | 2.36 Billion USD | -422.027% |
| Baxter International Inc. | 14.81 Billion USD | 16.702% |
| Becton, Dickinson and Company | 19.37 Billion USD | 36.305% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | -73.201% |
| Danaher Corporation | 23.89 Billion USD | 48.351% |
| Stryker Corporation | 20.49 Billion USD | 39.804% |
| Medtronic plc | 32.36 Billion USD | 61.874% |